CAR T-cell Therapies Produce Durable Remissions.
Two studies reported durable long-term remissions in patients with acute lymphoblastic leukemia treated with CAR T-cell therapies. One study focused on children and young adults treated with tisagenlecleucel; the other focused on adults who received infusions of 19-28z CAR T cells.